Regulation Of New Drug R D By The Food And Drug Administration 1974 Joint Hearings Before The Subcommittee On Health Of And The Subcommittee On Administrative Practice And Procedure Of The Judiciary Committee 93 2 September 25 27 1974

Does Congress do a good job of overseeing the work of the important legislative agencies--the EPA, FDA, OSHA, and others--that it has established to protect the public from some of the risks of modern technology? Combining analysis and anecdote, Christopher H. Foreman, Jr. looks into the oversight tools available to Congress, the variety of interest groups involved, the kinds of issues that arise between agencies and congressional committees, and the personal networks that affect relations between them; and he suggests what Congress can and should do to improve the process of social regulation. "Foreman adds substantially to our understanding of the role played by oversight. . . . A solid contribution toward understanding the nature of day-to-day congressional oversight."--Burdett Loomis, Journal of Politics " This book] is presented clearly, free from jargon, whether academic or governmental. . . . A solid discussion of oversight."--Jan P. Vermeer, Perspective "This is a thoughtful, effectively organized, and well-written book. Those concerned with legislative oversight will find it highly useful."--Morris S. Ogul, University of Pittsburgh Winner of the 1989 D. B. Hardeman Prize given by the Lyndon Baines Johnson Library for the best book on Congress in the twentieth century

The distance between medical and public priorities is exposed in four case studies that reveal the human choices governing scientific innnovation and explore the political, economic and social factors influencing those choices.